Results of faecal immunochemical test for XXXX screening, in average risk population, in a cohort of 1389 subjects.

@entity1 @entity1127 @entity548 @entity5 @entity1613 @entity14 @entity1241 @entity652
AIM: The aim of this study is to evaluate the usefulness of the @entity1241 ( @entity1241 ) in @entity14 screening, detection of @entity1613 and early @entity14 . MATERIAL AND METHODS: The study evaluated asymptomatic @entity1 with average risk (no personal or family antecedents of @entity1127 or @entity14 ), aged between 50 and 74 years. The presence of the occult @entity548 was tested with the immunochemical faecal test Hem Check 1 (Veda Lab, France). The subjects were not requested to have any dietary or drug restrictions. Colonoscopy was recommended in all subjects that tested positive. RESULTS: In our study, we had a total of 1389 @entity1 who met the inclusion criteria, with a mean age of 61.2    12.8 years, 565 (40.7%) @entity1 and 824 (59.3%) @entity1 . @entity1241 was positive in 87 individuals (6.3%). In 57/87 subjects (65.5%) with positive @entity1241 , colonoscopy was performed, while the rest of the subjects refused or delayed the investigation. A number of 5 (8.8%) @entity1 were not able to have a complete colonoscopy, due to @entity5 . The colonoscopies revealed in 10 cases (0.7%) @entity5 , in 29 cases (2.1%) advanced @entity652 and in 15 cases (1.1%) non advanced @entity652 from the total @entity1 in the study. The colonoscopies performed revealed a greater percentage of advanced @entity652 in the left colon compared to the right colon, 74.1% vs. 28.6% (p<0.001). CONCLUSIONS: In our study, @entity1241 had a positivity rate of 6.3%. The detection rate for advanced @entity5 was 2.8% (0.7% for @entity5 , 2.1% for advanced @entity652 ) in our study group. Adherence to colonoscopy for @entity1241 -positive subjects was 65.5%.
